Identification of dual inhibitor of phosphodiesterase 1B/10A using structure-based drug design approach
Schizophrenia is a neuropsychiatric disorder characterised by positive symptoms, negative symptoms, and cognitive impairment. Dopamine system dysfunction is strongly implicated in the aetiology of schizophrenia, where the hyperactivity in striatal dopamine and hypoactivity in cortical dopamine is co...
Saved in:
Main Authors: | Al-Nema, Mayasah, Gaurav, Anand, Lee, Vannajan Sanghiran, Gunasekaran, Baskaran, Lee, Ming Tatt, Okechukwu, Patrick |
---|---|
Format: | Article |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/28273/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structure-based discovery and bio-evaluation of a cyclopenta[4,5]thieno[2,3-: D] pyrimidin-4-one as a phosphodiesterase 10A inhibitor
by: Al-Nema, Mayasah, et al.
Published: (2022) -
Evaluation of the acute oral toxicity and antipsychotic activity of a dual inhibitor of PDE1B and PDE10A in rat model of schizophrenia
by: Al-Nema, Mayasah, et al.
Published: (2022) -
Docking based screening and molecular dynamics simulations to identify potential selective PDE4B inhibitor
by: Al-Nema, Mayasah, et al.
Published: (2020) -
Designing of 2,3-dihydrobenzofuran derivatives as inhibitors of PDE1B using pharmacophore screening, ensemble docking and molecular dynamics approach
by: Al-Nema, Mayasah, et al.
Published: (2023) -
Optimization of extraction methods for determination of phosphodiesterase-5 (PDE5) inhibitors in premix coffee
by: Zailina, A.M, et al.
Published: (2013)